Alembic Pharmaceuticals Ltd. has received final approval from the US Food and Drug Administration (USFDA) for its Fingolimod Capsules, 0.5 mg, the company announced on Saturday, April 25. The approval ...
New Delhi: Alembic Pharmaceuticals Limited has incorporated a wholly owned subsidiary, Alembic Pharmaceuticals GmbH, in Germany with an initial share capital of EUR 25,000, as part of its strategy to ...
New Delhi: Alembic Pharmaceuticals Limited has incorporated a new subsidiary, Alembic Lifesciences Philippines Inc., with a share capital of PHP 12 million, as part of its strategy to expand into the ...
Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its generic methotrexate injection, marking a significant addition to its oncology and ...
Vadodara: Alembic Pharmaceuticals is adding another regulated-market approval to its portfolio, reinforcing its presence in the US generics space with a key oncology and autoimmune therapy product.
Alembic Pharmaceuticals just got the green light from the US Food and Drug Administration for its generic methotrexate injection, available in two vial sizes. This medicine is used to treat certain ...
Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Methotrexate Injection USP, the company ...
Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...
Alembic Technologies raises $145M and buys an Nvidia-powered supercomputer to accelerate ‘causal AI’
Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...
Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...
Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...
app/ api/ # FastAPI route modules core/ # config, auth, db setup crud/ # data access helpers models/ # SQLAlchemy models schemas/ # request/response models services/ # business logic alembic/ # ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results